# Argenx SE: financial statements, quarterly

ARGX · Nasdaq · CIK 1697862 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/argx.md) · [Financials](/companies/argx/financials.md) · [Filings](/companies/argx/filings.md) · [Insiders](/companies/argx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/argx/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2018 (2018-12-31) | FY2019 (2019-12-31) | period not labelled (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [322](/filings/0001558370-22-003983.md) | [372](/filings/0001558370-23-004027.md) | [1,217](/filings/0001558370-24-003665.md) | [1,335](/filings/0001697862-25-000024.md) | [801](/filings/0001697862-26-000032.md) | [2,049](/filings/0001697862-26-000032.md) | [1,500](/filings/0001697862-26-000032.md) | [3,491](/filings/0001697862-26-000032.md) |
| Current assets | $m | not reported | [1,543](/filings/0001558370-22-003983.md) | [2,057](/filings/0001558370-23-004027.md) | [2,543](/filings/0001558370-24-003665.md) | [2,774](/filings/0001697862-25-000024.md) | [4,124](/filings/0001697862-26-000032.md) | [4,883](/filings/0001697862-26-000032.md) | [6,899](/filings/0001697862-26-000032.md) |
| Total assets | $m | not reported | [1,610](/filings/0001558370-22-003983.md) | [2,279](/filings/0001558370-23-004027.md) | [2,850](/filings/0001558370-24-003665.md) | [3,134](/filings/0001697862-25-000024.md) | [4,542](/filings/0001697862-26-000032.md) | [6,203](/filings/0001697862-26-000032.md) | [8,683](/filings/0001697862-26-000032.md) |
| Current liabilities | $m | not reported | [180](/filings/0001558370-22-003983.md) | [328](/filings/0001558370-23-004027.md) | [301](/filings/0001558370-24-003665.md) | [302](/filings/0001697862-25-000024.md) | [423](/filings/0001697862-26-000032.md) | [670](/filings/0001697862-26-000032.md) | [1,320](/filings/0001697862-26-000032.md) |
| Total liabilities | $m | not reported | [430](/filings/0001558370-22-003983.md) | [605](/filings/0001558370-23-004027.md) | [316](/filings/0001558370-24-003665.md) | [321](/filings/0001697862-25-000024.md) | [445](/filings/0001697862-26-000032.md) | [704](/filings/0001697862-26-000032.md) | [1,360](/filings/0001697862-26-000032.md) |
| Shareholders' equity | $m | [616](/filings/0001558370-22-003983.md) | [1,180](/filings/0001558370-23-004027.md) | [1,674](/filings/0001558370-24-003665.md) | [2,534](/filings/0001697862-25-000024.md) | [2,814](/filings/0001697862-26-000032.md) | [4,098](/filings/0001697862-26-000032.md) | [5,498](/filings/0001697862-26-000032.md) | [7,323](/filings/0001697862-26-000032.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 61,883,306 at 2025-12-31, from the cover of the [20-F filed 2026-03-19](/filings/0001697862-26-000032.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.